| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| loncastuximab tesirine | b-lymphocyte antigen cd19 | biotech | NA | drugbank | Reticulosarcoma[MeSHID:D008228] B-Lymphocytes[MeSHID:D001402] Relapse[MeSHID:D012008] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Follicular[MeSHID:D008224] |
NA | approved,investigational | binder |
| loncastuximab tesirine | b-lymphocyte surface antigen b4 | NA | Successful target | TTD | Reticulosarcoma[MeSHID:D008228] B-Lymphocytes[MeSHID:D001402] Relapse[MeSHID:D012008] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Follicular[MeSHID:D008224] |
NA | approved | unknown |
| click here to return to the previous page | ||||||||